United Therapeutics | UTHR - Interest Expense On Debt

Stock Price
473.66
Daily Change
-2.47 -0.52%
Monthly
-0.44%
Yearly
27.82%
Q1 Forecast
470.46

United Therapeutics reported $3M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Amarin USD 3K 5K Dec/2024
Ardelyx USD 5.8M 784K Sep/2025
Baxter International USD 58M 14M Sep/2025
Bayer EUR 762M 267M Sep/2025
BioCryst Pharmaceuticals USD 24.45M 381K Dec/2024
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Esperion Therapeutics USD 15.08M 1.36M Sep/2024
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Halozyme Therapeutics USD 4.3M 98K Sep/2025
Insmed USD 20.38M 863K Sep/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
J&J USD 18M 290M Sep/2025
Lexicon Pharmaceuticals USD 2.21M 2.74M Jun/2024
Moderna USD 12.14B 12.13B Sep/2025
Omeros USD 4.05M 5.16M Sep/2024
Pfizer USD 711M 59M Dec/2025
PTC Therapeutics USD 2.64B 2.61B Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Teva Pharmaceutical Industries USD 220M 17M Dec/2025
United Therapeutics USD 3M 4.3M Sep/2025
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025